OLB Q4 2025 Earnings Narrower Loss Beats Estimates as Stock Rises Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges SREA Q1 2026 Earnings Slight EPS Miss Reflects Modest Operational Headwinds CGEN Q1 2026 Earnings EPS Misses Estimates but Stock Rises 728 on Pipeline Progress Precipio Q2 2025 Earnings Company Reports Positive EPS of 005 Stock Declines 309 Hagerty Q1 2026 Earnings NarrowerThanExpected Loss Fails to Inspire Market